PACTR201503001057193已完成未知
A Randomized Trial to Evaluate Ebola Vaccine Efficacy and Safety in Guinea, West Africa-Part A: A Randomized Trial of Ring Vaccination to Evaluate Ebola Vaccine Efficacy and Safety in Guinea, West Africa. Part B- Safety and immunogenicity of VSV¿G/ZEBOV-GP among Frontline Workers
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 21,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 Year(s) 至 90 Year(s)（—）
- 性别
- All
入选标准
- •Individuals aged 18 years or older who live in the defined vaccination ring
- •Children 6 to 17 years following results from phase 2 study in Gabon, and following DSMB recommendation (3 July 2015)
排除标准
- •History of EVD (self-report or laboratory confirmed).
- •Pregnancy (verbal report) or breast-feeding. Women will be offered, but not required to take, a pregnancy test.
- •History of having received other investigational research agents in the previous 28 days.
- •Self- report of clinically important immunodeficiency condition, e.g. HIV/AIDS.
- •History of anaphylaxis to a vaccine or vaccine component
- •Severe illness that makes the person bed-bound or requiring hospitalization at the time of the vaccination.
研究者
相似试验
Unknown
不适用
STRIVE: Sierra Leone Trial to Introduce a Vaccine against EbolaPACTR201502001037220.S. Centers for Disease Control and Prevention6,000
已完成
不适用
Influenza vaccination strategies in haematological cancersInfluenza vaccinationHaematological malignancyInfection - Other infectious diseasesCancer - MyelomaCancer - Leukaemia - Chronic leukaemiaCancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphomaACTRN12622000454774Peter MacCallum Cancer Centre130
尚未招募
4 期
A trial to study role of influenza vaccine in reducing heart attack, stroke, hospitalisation and death in patients of heart failure.CTRI/2016/07/007081McMaster University3,500
进行中（未招募）
1 期
Pneumococcal vaccine against atherosclerosisHealthy male volunteersMedDRA version: 19.0Level: LLTClassification code 10003601Term: AtherosclerosisSystem Organ Class: 100000004866EUCTR2015-005650-35-NLCentre for Human Drug Research24
已完成
2 期
Proof-of-pharmacology clinical trial on a vaccine that elicits a protective humoral immune response against oxidized low density lipoproteiHypercholesterolemie10003216AtherosclerosisNL-OMON43410Centre for Human Drug Research24